MedPath

Clinical Study to Evaluate The Efficacy Of Higher Potency Repetition Against Same Potency Repetition Of Homoeopathic Medicine in Choronic Sickness

Recruiting
Registration Number
CTRI/2022/05/042880
Lead Sponsor
Not applicable
Brief Summary

The study is being conducted to evaluate the efficacy of repetition of higher potency compared to a repetition of the same potency of the indicated Homoeopathic medication having alternating action on non-improving chronic patients. and to compare the superiority of Centicimal potency against LM Potency of the indicated homoeopathic medication having alternating action on non-improving chronic patients. 17 medicines have shown alternating action (According to Dr. Hahnemann’s different writings; Post Hahnemannian Stalwarts are not included): Arnica montana, Arsenicum album, Belladonna, Bryonia alba, Chamomilla, China officinalis, Digitalis purpura, Hyoscyamusnigre, Ignatiaamara, Magnespolusambu, Manganumaceticum, Menyanthes, Phosphoric  acid, Pulsatilla, Rhustoxicodendron, Spigelia, Stannum metallicum. If the prescriber of these medicines (selected on strict Homoeopathic principles) finds that no improvement follows, he should repeat the same medicine in the same potency and the improvement will soon follow. Every patient will be assessed periodically to follow up the reaction of the remedy through clinical assessment as well as relevant investigations. The usual follow up will be done at an interval of 2 weeks. Total 3 follow ups will be done after Screening-Visit. Oral route will be chosen for the administration of medicines. Medicines will be dispensed in liquid form using distilled water only on Day 1 and Assessment using ORIDL Scale will be done on Day 1, 15, 30 and 45.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Patients prescribed medicines having alternating action (17 Medicines), in Centesimal Scale or LM Scale on Pre-Screening Visit and no improvement reported on next visit (Screening Visit).
  • Patients from different socio-economic status.
  • Patient with chronic complaints.
Exclusion Criteria
  • Patient suffering from any life threatening disease.
  • Patients having very poor general condition.
  • Patient not willing to participate in the study.
  • Patients with acute complaints.
  • Patients with Decimal Scale or Mother Tinctures Patients who have received any homoeopathic medicine within last 3 months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in in main complaint, Overall coping with the disorder and Overall well beingDay 1 (Screening visit), 15, 30 and Day 45 (End of the study visit)
Secondary Outcome Measures
NameTimeMethod
superiority of Centicimal potency against LM Potency of the indicated homoeopathic medication having alternating action on non-improving chronic patientsDay 1 (Screening visit), 15, 30 and Day 45 (End of the study visit)

Trial Locations

Locations (1)

All India Institute of Medical Sciences Raipur

🇮🇳

Raipur, CHHATTISGARH, India

All India Institute of Medical Sciences Raipur
🇮🇳Raipur, CHHATTISGARH, India
Dr Ashutosh Tripathi
Principal investigator
8518887337
drattripathihmo@aiimsraipur.edu.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.